Coronavirus: AstraZeneca to trial Covid-19 vaccine combination with Russia’s Sputnik V

Pharmaceutical giant AstraZeneca’s Russian branch said on Friday it would use part of Russia’s home-made Sputnik V Covid-19 vaccine in further clinical trials.“Today we announce a clinical trial programme to assess safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute,” AstraZeneca said in a statement published on its website in English and Russian.The pharmaceutical company said…

Read the original article at South China Morning Post